TrialThe European respiratory journal2025

Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies.

Marius M Hoeper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.